🔎 Trials Near Me

Akèy › Limfòm Burkitt › Kansas › Kansas City

Etid klinik pou Limfòm Burkitt nan Kansas City, KS

4 etid pou Limfòm Burkitt ap chèche patisipan nan sit nan ak bò kote Kansas City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Ap rekriteFaz 3
  • University of Kansas Cancer Center, Kansas City
Laj 18 a 39 · Tout sèks · Mizajou Oct 2, 2026 · NCT03150693

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Ap rekriteFaz 2
  • University of Kansas Cancer Center, Kansas City
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT03739814

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Ap rekriteFaz 2
  • Children's Mercy Hospital, Kansas City
Laj 7 a 25 · Tout sèks · Mizajou Aug 19, 2026 · NCT05082519

Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene

Ap rekriteFaz 1/2
  • University of Kansas Cancer Center, Kansas City
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07069699

Etid Limfòm Burkitt nan lòt vil

Lòt etid nan Kansas City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.